Tonix Pharmaceuticals Holding Corp. (TNXP) is a publicly traded Healthcare sector company. As of October 19, 2026, TNXP trades at $6.16 with a market cap of $103.59M and a P/E ratio of -0.56. TNXP moved +1.99% today. Year to date, TNXP is -61.33%; over the trailing twelve months it is -67.89%. Its 52-week range spans $6.01 to $69.97. Analyst consensus is strong buy with an average price target of $38.00. Rallies surfaces TNXP's financials, insider trades, hedge fund holdings, congressional trades, analyst ratings, and AI-generated research below.
Rallies tracks hedge fund and 13F ownership for TNXP, including fund holders, share counts, and position changes when data is available.
| Metric | Value |
|---|---|
| Price | $6.16 |
| Market Cap | $103.59M |
| P/E Ratio | -0.56 |
| EPS | $-13.06 |
| Dividend Yield | 0.00% |
| 52-Week High | $69.97 |
| 52-Week Low | $6.01 |
| Volume | 1.14K |
| Avg Volume | 0 |
| Revenue (TTM) | $29.10M |
| Net Income | $-159.67M |
| Gross Margin | 83.83% |
3 analysts cover TNXP: 0 strong buy, 3 buy, 0 hold, 0 sell, 0 strong sell. Consensus rating is strong buy. Average price target: $38.00.